Buffalo, Minnesota, United States
Executive Professional Background Description Sadik Semih Demiralp is a pioneering medical technology entrepreneur and interventional specialist with more than four decades of leadership in cardiovascular, interventional radiology, and implantable medical device innovation. His career spans the early evolution of modern interventional medicine, where he played a foundational role in introducing, developing, and commercializing breakthrough technologies across multiple therapeutic fields. Beginning in the early 1980s, Mr. Demiralp was directly involved in the clinical adoption and advancement of cardiac rhythm management systems, pacemaker implantation techniques, and electrophysiology applications. He subsequently became a key figure in the introduction of interventional cardiology procedures, including some of the earliest PTCA interventions, guidewire innovations, and valvuloplasty techniques. Over the following decades, he contributed to the first implementations of numerous life-saving procedures and technologies, including vascular stenting, IVUS imaging, TIPSS procedures, and implantable defibrillator systems. In parallel with his clinical and technical contributions, Mr. Demiralp founded and led multiple medical technology companies focused on distribution, manufacturing, and product development. As Founder and CEO of several organizations—including ETA Co. Ltd., Hospitek S.A., Hospimed S.A., Seta S.A., NDI Medical Technologies, and later Neuravention, Inc.—he played a central role in building infrastructure for interventional medicine, introducing advanced therapies into new markets, and establishing certified manufacturing operations that achieved ISO and CE regulatory milestones. His work has consistently focused on identifying unmet clinical needs and translating them into practical, scalable medical device solutions. This approach led to multiple patents awarded by both the European Patent Office and the United States Patent and Trademark Office, particularly in the field of implantable therapeutic systems and embolization technologies. Today, as President & CEO of Neuravention, Inc., Mr. Demiralp continues this trajectory by developing next-generation neurovascular technologies, including proprietary embolic coil systems designed to improve aneurysm treatment outcomes and procedural efficiency. His career reflects a rare combination of clinical insight, engineering vision, regulatory experience, and entrepreneurial execution, positioning him as a long-standing contributor to the global advancement of interventional medicine.
Founder New Medical Technology Products sales and marketing and production.
First Custom Pack Tray manufacturer for Interventional Procedures and receives first CE marking with largest Class 10000 Clean room in Europe in 2005.
Become exclusive distributor for non-Pharmaceutical Companies for former Schneider/Pfizer and former AMS/Pfizer.